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Background
Epidemiological studies suggest that diabetes mellitus
increases the risk of onset of Alzheimer disease (AD).
However, the underlying mechanisms have not been
fully understood. Retrospective studies indicate that dia-
betes does not increase senile plaques. On the other hand,
a Japanese cohort, Hisayama study suggested that insulin
resistance in midlife increased the risk of development of
senile plaques. Therefore, the aim of this study is to under-
stand the mechanisms by which diabetes increase the risk
of AD by dividing them into two phases; 1) before and 2)
after the development of senile plaques.
Methods
1) To test whether insulin resistance increases Abeta
accumulation in the brain, we fed wild-type mice with a
high-fat diet and measured the levels of Abeta in the
brain. 2) To investigate the effects of diabetes on AD, we
further analyzed the phenotypes of APP+ob/ob mice [1],
which showed the increased cerebral amyloid angiopathy
and impaired insulin signaling, especially focusing on tau
phosphorylation.
Results
1) Six months on a high fat diet increased Abeta40 in
B6C mice brain. 2) 18 month old APP+ob/ob mice
showed highly increased level of tau phosphorylation in
the brain. Furthermore, a high fat diet increased plasma
Abeta levels in APP/PS1 mice, but not in wild type mice.
Conclusion
Tau phosphorylation is increased by diabetes in APP
mice, suggesting that Abeta is prerequisite, but insuffi-
cient to cause tau phosphorylation in vivo. Abeta accu-
mulation, insulin signaling and tau phosphorylation
might play essential roles in the pathological interaction
between AD and diabetes [2]. Of note, a vicious cycle
likely underlies the interaction between AD and diabetes.
High fat diet-induced elevation of plasma Abeta level
might be involved in this mutual pathological interaction
between the diseases [3,4]. These results suggest that
diabetes disrupts homeostasis against AD.
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